Santyl and Cymbalta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Santyl (collagenase) and Cymbalta (duloxetine hydrochloride). Common drug interactions include weight decreased among females and cellulitis among males.

The phase IV clinical study analyzes what interactions people have when they take Santyl and Cymbalta. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.

What is Santyl?

Santyl has active ingredients of collagenase. eHealthMe is studying from 1,479 Santyl users. Check the latest studies of Santyl.

What is Cymbalta?

Cymbalta has active ingredients of duloxetine hydrochloride. It is often used in depression. eHealthMe is studying from 154,973 Cymbalta users. Check the latest studies of Cymbalta.



On Jul, 19, 2026

32 people who take Santyl and Cymbalta together, and have interactions are studied.

Santyl and Cymbalta drug interactions.

What are the common drug interactions of Santyl and Cymbalta, by gender? *:

female:

  1. Weight decreased
  2. Chronic kidney disease
  3. Poor peripheral circulation
  4. Skin exfoliation (removal of the oldest dead skin cells)
  5. Crying
  6. Scab (a hard coating on the skin formed during the wound healing)
  7. Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)
  8. Cardiac failure
  9. Drug ineffective
  10. Ischaemic limb pain (pain due to sudden lack of blood flow to a limb)

male:

  1. Cellulitis (infection under the skin)
  2. Acute respiratory failure
  3. Application site irritation
  4. Behcet's syndrome (involves inflammation of the blood vessels)
  5. Blood pressure decreased
  6. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  7. Colitis (inflammation of colon)
  8. Death
  9. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  10. Intestinal polyp (small growths in the bowel with the potential for further growth)

What are the common drug interactions of Santyl and Cymbalta, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Chronic kidney disease
  2. Leukocytosis (increased white blood cells)
  3. Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
  4. Renal injury (kidney injury)
  5. Renal tubular necrosis (death of kidney tubules)
  6. Sepsis (a severe blood infection that can lead to organ failure and death)
  7. Urinary tract infection
  8. Cellulitis (infection under the skin)
  9. Groin infection (infection in groin)
  10. Renal failure (kidney dysfunction)

50-59:

  1. Blood pressure decreased
  2. Aortic aneurysm (enlargement of an aortic artery caused by a weakening of the artery wall)
  3. Behcet's syndrome (involves inflammation of the blood vessels)
  4. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  5. Colitis (inflammation of colon)
  6. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  7. Intestinal polyp (small growths in the bowel with the potential for further growth)
  8. Pulmonary mass
  9. Renal cyst (kidney cyst)
  10. Renal disorder (kidney disease)

60+:

  1. Wound complication
  2. Application site erythema (redness of the skin at application site)
  3. Diastolic dysfunction
  4. Drug ineffective
  5. Dry gangrene (diminished blood supply due to vascular problems)
  6. Ear infection
  7. Foot amputation (loss of foot)
  8. Gangrene (body tissue dies)
  9. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  10. Hyperkalaemia (damage to or disease of the kidney)

What are the existing conditions these people have? *

  1. Pain: 16 people, 50.00%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 11 people, 34.38%
  3. Wound: 10 people, 31.25%
  4. Constipation: 9 people, 28.12%
  5. Diabetes: 9 people, 28.12%
  6. Hypersensitivity: 8 people, 25.00%
  7. High Blood Cholesterol: 8 people, 25.00%
  8. Muscle Spasms (muscle contraction): 8 people, 25.00%
  9. High Blood Pressure: 7 people, 21.88%
  10. Faeces Hard: 6 people, 18.75%

* Approximation only. Some reports may have incomplete information.

Do you take Santyl and Cymbalta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Santyl and Cymbalta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Santyl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cymbalta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Santyl and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cymbalta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on collagenase and duloxetine hydrochloride (the active ingredients of Santyl and Cymbalta, respectively), and Santyl and Cymbalta (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: